All
- All
- Product Management
- News
- Introduction
- Enterprise outlets
- FAQ
- Enterprise Video
- Enterprise Atlas
Chuangyuan Biotechnology's independently developed local strains have been granted a national invention patent.
On September 9, 2022, Tianjin Chuangyuan Biotechnology Co., Ltd. developed and applied for the patent "A Fermented Lactobacillus IOB802 and Its Use in Improving Sleep Disorders" (Patent No.: ZL 202210571582.3)National Intellectual Property Administrationissued the invention patent certificate.


Chuangyuan Biotechnology, invention patent, probiotics, Tianjin Chuangyuan Biotechnology Co., Ltd., patent
Related News